Crystalline EGFR - matuzumab complex and matuzumab mimetics obtained thereof

Details for Australian Patent Application No. 2008306202 (hide)

Owner Merck Patent GmbH The Trustees of the University of Pennsylvania

Inventors Schmiedel, Judith; Ferguson, Kathryn M.; Knoechel, Thorsten

Agent Davies Collison Cave

Pub. Number AU-A-2008306202

PCT Pub. Number WO2009/043490

Priority 60/997,502 02.10.07 US

Filing date 19 September 2008

Wipo publication date 9 April 2009

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

27 May 2010 PCT application entered the National Phase

  PCT publication WO2009/043490 Priority application(s): WO2009/043490

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008306207-Use of sulfonyl-substituted 2-sulfonylaminobenzoic acid Nphenylamides in the treatment of pain

2008306194-Security element for the identification of a security document and method for producing it